Abstract
| Original language | English |
|---|---|
| Journal | BMJ Open |
| Volume | 6 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - 2016 |
Keywords
- cerebral venous thrombosis
- ischemic stroke
Fingerprint
Dive into the research topics of 'Towards the genetic basis of cerebral venous thrombosis - The BEAST Consortium: A study protocol'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Towards the genetic basis of cerebral venous thrombosis - The BEAST Consortium: A study protocol. / Cotlarciuc, Ioana; Marjot, Thomas; Khan, Muhammad S. et al.
In: BMJ Open, Vol. 6, No. 11, 2016.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Towards the genetic basis of cerebral venous thrombosis - The BEAST Consortium: A study protocol
AU - Cotlarciuc, Ioana
AU - Marjot, Thomas
AU - Khan, Muhammad S.
AU - Hiltunen, Sini
AU - Haapaniemi, Elena
AU - Metso, Tiina M.
AU - Putaala, Jukka
AU - Zuurbier, Susanna M.
AU - Brouwer, M. C.
AU - Passamonti, S.M.
AU - Bucciarelli, P.
AU - Pappalardo, Elisa
AU - Patel, Timil
AU - Costa, P.
AU - Colombi, M.
AU - Canhão, Patrícia
AU - Tkach, Aleksander
AU - Santacroce, Rosa
AU - Margaglione, M.
AU - Favuzzi, G.
AU - Grandone, E.
AU - Colaizzo, D.
AU - Spengos, Konstantinos
AU - Arauz, Antonio
AU - Hodge, A.
AU - Ditta, Reina
AU - Debette, S.
AU - Zedde, M.
AU - Pare, Guillame
AU - Ferro, Jose M.
AU - Thijs, V.
AU - Pezzini, A.
AU - Majersik, Jennifer J.
AU - Martinelli, I.
AU - Coutinho, Jonathan M.
AU - Tatlisumak, Turgut
AU - Sharma, P. P.
N1 - Export Date: 27 March 2017 Correspondence Address: Cotlarciuc, I.; Institute of Cardiovascular Research Royal Holloway, University of LondonUnited Kingdom; email: ioana.cotlarciuc@rhul.ac.uk Funding details: DCEPT, Dowager Countess Eleanor Peel Trust Funding text: BEAST has received financial support from the Dowager Countess Eleanor Peel Trust and from the Stroke Association. References: Ferro, J.M., Canhao, P., Stam, J., Prognosis of cerebral vein and dural sinus thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT) (2004) Stroke, 35, pp. 664-670; Coutinho, J.M., Zuurbier, S.M., Aramideh, M., The incidence of cerebral venous thrombosis: A cross-sectional study (2012) Stroke, 43, pp. 3375-3377; Stam, J., Thrombosis of the cerebral veins and sinuses (2005) N Engl J Med, 352, pp. 1791-1798; Coutinho, J.M., Zuurbier, S.M., Stam, J., Declining mortality in cerebral venous thrombosis: A systematic review (2014) Stroke, 45, pp. 1338-1341; Corvol, J.C., Oppenheim, C., Manai, R., Diffusion-weighted magnetic resonance imaging in a case of cerebral venous thrombosis (1998) Stroke, 29, pp. 2649-2652; Yoshikawa, T., Abe, O., Tsuchiya, K., Diffusion-weighted magnetic resonance imaging of dural sinus thrombosis (2002) Neuroradiology, 44, pp. 481-488; Ehtisham, A., Stern, B., Cerebral venous thrombosis: A review (2006) Neurologist, 12, pp. 32-38; Spencer, F.A., Gore, J.M., Lessard, D., Venous thromboembolism in the elderly: A community-based perspective (2008) Thromb Haemostasis, 100, pp. 780-788; Lim, H.Y., Ng, C., Donnan, G., Ten years of cerebral venous thrombosis: Male gender and myeloproliferative neoplasm is associated with thrombotic recurrence in unprovoked events (2016) J Thromb Thrombolysis, 42, pp. 423-431; Miranda, B., Ferro, J.M., Canhão, P., Venous thromboembolic events after cerebral vein thrombosis (2010) Stroke, 41, pp. 1901-1906; Koopman, K., Uyttenboogaart, M., Vroomen, P.C., Risk factors for cerebral venous thrombosis and deep venous thrombosis in patients aged between 15 and 50 years (2009) Thromb Haemostasis, 102, pp. 611-798; Martinelli, I., Sacchi, E., Landi, G., High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives (1998) N Engl J Med, 338, pp. 1793-1797; Martinelli, I., Battaglioli, T., Pedotti, P., Hyperhomocysteinemia in cerebral vein thrombosis (2003) Blood, 102, pp. 1363-1366; Junker, R., Nabavi, D.G., Wolff, E., Plasminogen activator inhibitor-1 4G/4G-genotype is associated with cerebral sinus thrombosis in factor v Leiden carriers (1998) Thromb Haemostasis, 80, pp. 706-707; Le Cam-Duchez, V., Bagan-Triquenot, A., Barbay, V., The G79A polymorphism of protein Z gene is an independent risk factor for cerebral venous thrombosis (2008) J Neurol, 255, pp. 1521-1525; Passamonti, S.M., Biguzzi, E., Cazzola, M., The JAK2 V617F mutation in patients with cerebral venous thrombosis (2012) J Thromb Haemost, 10, pp. 998-1003; Marjot, T., Yadav, S., Hasan, N., Genes associated with adult cerebral venous thrombosis (2010) Stroke, 42, pp. 913-918; Cheng, Y.C., Cole, J.W., Kittner, S.J., Genetics of ischemic stroke in young adults (2014) Circulation, 7, pp. 383-392; Cheng, Y.C., O'Connell, J.R., Cole, J.W., (2011) Genome-wide Association Analysis of Ischemic Stroke in Young Adults, 1, pp. 505-514. , G3 (Bethesda); Schulz, U.G.R., Flossmann, E., Rothwell, P.M., Heritability of ischemic stroke in relation to age, vascular risk factors, and subtypes of incident stroke in population-based studies (2004) Stroke, 35, pp. 819-824; Deschiens, M.A., Conard, J., Horellou, M.H., Coagulation studies, factor v Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis (1996) Stroke, 27, pp. 1724-1730; Rodeghiero, F., Tosetto, A., Activated protein C resistance and factor v Leiden mutation are independent risk factors for venous thromboembolism (1999) Ann Intern Med, 130, pp. 643-650; Salomon, O., Steinberg, D.M., Zivelin, A., Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: Prevalence and risk assessment (1999) Arterioscler Thromb Vasc Biol, 19, pp. 511-518; Dentali, F., Crowther, M., Ageno, W., Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: A meta-analysis (2006) Blood, 107, pp. 2766-2773; Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception (1995) Lancet, 346, pp. 1575-1582. , Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study; Coutinho, J.M., Ferro, J.M., Canhão, P., Cerebral venous and sinus thrombosis in women (2009) Stroke, 40, pp. 2356-2361; Lao, O., Lu, T.T., Nothnagel, M., Correlation between genetic and geographic structure in Europe (2008) Curr Biol, 18, pp. 1241-1248; Power, C., Elliott, J., Cohort profile: 1958 British birth cohort (National Child Development Study) (2006) Int J Epidemiol, 35, pp. 34-41; Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls (2007) Nature, 447, pp. 661-678; Guo, Y., He, J., Zhao, S., Illumina human exome genotyping array clustering and quality control (2014) Nat Protocols, 9, pp. 2643-2662; Selinger-Leneman, H., Genin, E., Norris, J.M., Does accounting for gene-environment (GxE) interaction increase the power to detect the effect of a gene in a multifactorial disease? (2003) Genet Epidemiol, 24, pp. 200-207; Skol, A.D., Scott, L.J., Abecasis, G.R., Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies (2006) Nat Genet, 38, pp. 209-213; McCarthy, M.I., Abecasis, G.R., Cardon, L.R., Genome-wide association studies for complex traits: Consensus, uncertainty and challenges (2008) Nat Rev Genet, 9, pp. 356-369; Ikram, M.A., Seshadri, S., Bis, J.C., Genomewide Association Studies of Stroke (2009) N Engl J Med, 360, pp. 1718-1728; (2010) N Engl J Med, 362, pp. 1547-1550. , International Stroke Genetics Consortium; Wellcome Trust Case-Control Consortium 2. Failure to validate association between 12p13 variants and ischemic stroke; Olsson, S., Melander, O., Jood, K., Genetic variant on chromosome 12p13 does not show association to ischemic stroke in 3 Swedish case-control studies (2011) Stroke, 42, pp. 214-216; Bellenguez, C., Bevan, S., Gschwendtner, A., Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke (2012) Nat Genet, 44, pp. 328-333; Traylor, M., Farrall, M., Holliday, E.G., Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): A meta-analysis of genome-wide association studies (2012) Lancet Neurol, 11, pp. 951-962; Kilarski, L.L., Achterberg, S., Devan, W.J., Meta-analysis in more than 17, 900 cases of ischemic stroke reveals a novel association at 12q24.12 (2014) Neurology, 83, pp. 678-685; Meschia, J.F., Stroke genome-wide association studies: The large numbers imperative (2010) Stroke, 41, pp. 579-580; Kryukov, G.V., Pennacchio, L.A., Sunyaev, S.R., Most rare missense alleles are deleterious in humans: Implications for complex disease and association studies (2007) Am J Hum Genet, 80, pp. 727-739; Bamshad, M.J., Ng, S.B., Bigham, A.W., Exome sequencing as a tool for Mendelian disease gene discovery (2011) Nat Rev Genet, 12, pp. 745-755; Ku, C.S., Cooper, D.N., Polychronakos, C., Exome sequencing: Dual role as a discovery and diagnostic tool (2012) Ann Neurol, 71, pp. 5-14
PY - 2016
Y1 - 2016
N2 - Introduction Cerebral venous thrombosis (CVT) is a rare cerebrovascular condition accounting for
AB - Introduction Cerebral venous thrombosis (CVT) is a rare cerebrovascular condition accounting for
KW - cerebral venous thrombosis
KW - ischemic stroke
U2 - 10.1136/bmjopen-2016-012351
DO - 10.1136/bmjopen-2016-012351
M3 - Article
VL - 6
JO - BMJ Open
JF - BMJ Open
SN - 2044-6055
IS - 11
ER -